May 15, 2025
The National Stock Exchange of India Limited Exchange Plaza, Bandra-Kurla Complex, Bandra (E), Mumbai - 400 051. Scrip Code: STAR | The BSE Limited Phiroze Jeejeebhoy Towers, Dalal Street, Mumbai - 400 001. Scrip Code: 532531 |
Dear Sirs,
Subject: Intimation on Board MeetingPursuant to Regulation 29(1) of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, we hereby inform you that a meeting of Board of Directors of the Company is scheduled to be held on Thursday, May 22, 2025, inter alia:
To consider and approve the audited financial results (standalone and consolidated) of the Company for the quarter and financial year ended March 31, 2025; and
To consider and recommend final dividend, if any, on the equity shares of the Company for the financial year ended March 31, 2025.
Further, as per the provisions of the Company's Code of Conduct for Prohibition of Insider Trading, trading window for designated persons of the Company has been closed from April 1, 2025 and shall open after 48 hrs post declaration of financial results of the Company.
The above-mentioned information will also be available on website of the Company at https://www.strides.com.
This is for your kind information and record purposes. Thanks & Regards,
For Strides Pharma Science Limited,
MANJULA R
Digitally signed by MANJULA R
Date: 2025.05.15
19:25:52 +05'30'
Manjula Ramamurthy Company Secretary & Compliance Officer ICSI Membership No. A30515 Strides Pharma Science LimitedCIN: L24230MH1990PLC057062
Corp. Off: Strides House, Bilekahalli, Bannerghatta Road, Bengaluru - 560 076, India Tel: +91-80-6784 0000 Fax: +91 80 6784 0700 Regd Off: 'Cyber One', Unit No. 902, Plot No. 4 & 6, Sector 30A, Vashi, Navi Mumbai - 400 703, India Tel:+91-22-2789 2924/ 3199corpcomm@strides.com; https://www.strides.com